The Cinphloro IBS-D study evaluated novel therapeutic strategies for patients with irritable bowel syndrome with diarrhea (IBS-D), a functional gastrointestinal disorder characterized by chronic abdominal pain, altered bowel habits, and increased stool frequency.

This study has concluded.